Logo-npj

J Nephropharmacol. 2021;10(1): e05. doi: 10.34172/npj.2021.05

Mini-Review

An overview of complications associated with deferoxamine therapy in thalassemia

Bijan Keikhaei 1 ORCID, Neda Farmani-Anooshe 1, Mohammad Bahadoram 1 * ORCID, Mohammad-Reza Mahmoudian-Sani 1, Kosar Alikhani 1 ORCID, Ammar Helalinasab 1 ORCID

Cited by CrossRef: 3

1- Zainuddin N, Ismail W, Nalliappan P, Nalliappan H. Knowledge, Attitude and Practice of Conventional Medicine Among Thalassaemia In Malaysia: Conceptual paper . E-BPJ. 2024;9(30):85 [Crossref]
2- Bardestani A, Ebrahimpour S, Esmaeili A, Esmaeili A. Quercetin attenuates neurotoxicity induced by iron oxide nanoparticles. J Nanobiotechnol. 2021;19(1) [Crossref]
3- Alshamsi S, Hamidi S, Narci H. Healthcare resource utilization and direct costs of transfusion-dependent thalassemia patients in Dubai, United Arab Emirates: a retrospective cost-of-illness study. BMC Health Serv Res. 2022;22(1) [Crossref]
4- Eghbali A, Ghaffari K, shaykh Baygloo R, Eghbali A, Ghasemi A. Polyneuropathy Associated with Age of Starting the Transfusion and Serum Ferritin Level in Iranian Patients with Thalassemia Major and Intermedia. Hemoglobin. 2023;47(2):42 [Crossref]